default search action

combined dblp search
author search
venue search
publication search

ask others

Marius Kaseta

> Home > Persons

Person information

Refine list

refinements active!

zoomed in on ?? of ?? records

view refined list in

export refined list as

showing all ?? records

2010 – 2019

see FAQ

What is the meaning of the colors in the publication lists?

2010
[j2]
- view
  authority control:
- export record
  dblp key:
  - journals/artmed/VerikasGBHUK10
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/artmed/VerikasGBHUK10
Antanas Verikas, Adas Gelzinis, Marija Bacauskiene, Magnus Hållander, Virgilijus Uloza, Marius Kaseta:
Combining image, voice, and the patient's questionnaire data to categorize laryngeal disorders. Artif. Intell. Medicine 49(1): 43-50 (2010)

2000 – 2009

see FAQ

What is the meaning of the colors in the publication lists?

2009
[j1]
- view
  authority control:
- export record
  dblp key:
  - journals/cbm/VerikasGBUK09
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/cbm/VerikasGBUK09
Antanas Verikas, Adas Gelzinis, Marija Bacauskiene, Virgilijus Uloza, Marius Kaseta:
Using the patient's questionnaire data to screen laryngeal disorders. Comput. Biol. Medicine 39(2): 148-155 (2009)
2007
[c1]
- view
  - electronic edition @ isca-archive.org (open access)
  - details & citations
- export record
  dblp key:
  - conf/maveba/BacauskieneGKKPUV07
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/maveba/BacauskieneGKKPUV07
Marija Bacauskiene, Adas Gelzinis, Marius Kaseta, Marina Kovalenko, Ruta Pribuisiene, Virgilijus Uloza, Antanas Verikas:
Multiple feature sets and genetic search based discrimination of pathological voices. MAVEBA 2007: 195-198

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.